Načítá se...

Novel Antigens for RSV Vaccines

Respiratory syncytial virus (RSV) remains a leading global cause of infant mortality and adult morbidity. Infection, which recurs throughout life, elicits only short-lived immunity. The development of a safe and efficacious vaccine has, thus far, been elusive. Recent technological advances, however,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Curr Opin Immunol
Hlavní autoři: Graham, Barney S., Modjarrad, Kayvon, McLellan, Jason S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4553118/
https://ncbi.nlm.nih.gov/pubmed/26070108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2015.04.005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!